Home › Pick Up Celgene After 9% Pullback - It's Ready
 

Keywords :   


Pick Up Celgene After 9% Pullback - It's Ready

2015-06-20 19:05:23| Biotech - Topix.net

The oncology treatment sector is expected grow 7% annually over next five years, and Celgene is forecast to have high double-digit earnings growth annually over next several years. Celgene Corporation is seeing a lot of success from its bone marrow cancer treatment drug Revlimid among its other cancer fighting drug products.

Tags: its ready pick pullback

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Hurricane Beryl Public Advisory Number 8A
30.06Hurricane Beryl Graphics
30.06Eastern North Pacific Tropical Weather Outlook
30.06Atlantic Tropical Weather Outlook
30.06Hurricane Beryl Update Statement
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Forecast Discussion Number 8
More »